Human bodies fail with age. Science can finally overcome this built-in obsolescence

Human bodies are the product of millions of years of evolution and they are far from perfect. There are lots of things that nature could have done better. Things fail. However, our ancestors lived through the failings and so will we. Or perhaps not.

Developments in science in the form of stem cell therapy mean that damaged organs can now be repaired. Thus avoiding the natural lead to death.

In simple terms, if any organ or part of a human body is infected by disease, the human body will naturally react to defend itself. It will deploy white blood cells and body temperature will increase. If the body fails to destroy the micro-organisms causing the disease then the microbes will produce toxic substances and the infected organ will fail. If this is a major organ then the body will take a big hit.

A failed heart will lead to reduced cardiac output and difficulties in pumping blood through the body. A failed brain can lead to paralysis and the damage can affect other organs. Failed kidneys can lead to the inability to remove potassium from the bloodstream, which in turn can lead to abnormal heart rhythms and potentially sudden death.

Stem cell therapy can fix damaged organs and can therefore prevent a body from failing.

Cell Therapy Ltd is developing regenerative medicines that will save lives. They have an extremely unique approach towards stem cell therapy, in that, they haven’t just found one stem cell to fix all ailments, as have other stem cell companies, but they have actually been successful in pin pointing very rare and potent tissue specific stem cells. This unprecedented class of cells is then engineered into unique disease-specific cellular regenerative medicines whereby each medicine is disease specific. Thus enabling the treatment of different parts of the body with unique and precise treatment.

Science can most definitely overcome the human body’s obsolescence. If stem cell therapy can fix damaged organs rather than simply just prevent them from getting worse, as current medicine can only achieve, then humans can live longer and healthier and quality of life can be improved. Science can indeed stop bodies from failing.

Disease specific and tissue specific stem cell therapy will save and transform lives around the world

Stem Cell Therapy is extremely promising in terms of being able, in the future, to cure failed organs. Stem cells can help us to understand and treat different diseases, injuries and health related problems.

Presently, the most common use of stem cell therapy is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system, or to rejuvenate the blood system following treatments of certain cancers. Currently, more than 26,000 patients are treated with blood stem cells in Europe every year.

Also, the skin. Skin stem cells have been successfully used to grow skin grafts for patients that have suffered from severe bodily burns. At the moment, the burns would need to be life-threatening before the option of stem cell therapy is used. There is still a way to go with this and scientists are continuing their research into skin stem cells since the new skin currently has no hair follicles and cannot sweat.

Furthermore, the recent conditional approval in Europe of Holoclar, means that stem cells can be used to repair damage to the surface of the eye after an injury such as a chemical burn.

Other applications of stem cells to treat different parts of the body are continuing to be explored and it can take years for them to be thoroughly investigated, approved and ready for market, following all the necessary clinical trials.

Ajan Reginald, Executive Director of Cell Therapy Ltd and Nobel Prize Winner Professor Sir Martin Evans are dedicated to using stem cells to develop life-saving and life-altering regenerative medicines. Whereas most stem cell companies follow a philosophy of having one cell that can treat all diseases, Ajan Reginald and Professor Sir Martin Evans have discovered disease-specific and tissue specific progenitor cells and have invented targeted regenerative medicines from these cells.

So far, two such medicines have both passed stage II of clinical trials; Heartcel, to repair broken hearts and Tendoncel, to regenerate injured tendons near the surface of the skin.

Stem cells are the body’s master cells. Unlike other cells, stem cells can turn into almost any other cell in the body. If these new medicines prove to work, they could revolutionise the way we treat disease and could save and transform the lives of billions of people around the world.

Cell Therapy Ltd. Grants Japan License To Daiichi Sankyo For Its Heart Regeneration Medicine, Heartcel

Cell Therapy Ltd. (CTL) today announced the granting of the Japan license for its innovative cardiac regeneration medicine, Heartcel™ (immuno-modulatory progenitor [iMP] cells) to Daiichi Sankyo. Daiichi Sankyo will undertake all development, regulatory and commercial activities for iMP cells in the territory of Japan only, while CTL retains its worldwide rights outside of Japan as well as global manufacturing responsibilities. Under the terms of the agreement, CTL receives a £12.5 million upfront licensing fee and additional milestone payments and royalties.

Read the full story at: 

The first skin to eye stem cell transplant in humans was successful

Researchers in the US have successfully transplanted stem cells derived from skin into the back of an eye in an attempt to restore vision. A small section of skin was taken from the patient’s arm, cells where then collected and modified. The modified cells “known as IPSC” were converted into eye cells which were then transplanted into the patients eye.

The cells survived and contributed towards improved vision.

The patient suffered from age related macular degeneration which had not responded to any previous treatments. The slight improvement in vision showed the massive potential for stem cell therapy and regenerative medicine.

IPSCs are adult cells are converted back into an embryonic stem cell state which allows them to take on the role of other cells within the body, like a programmable template.

Original source: